# Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients

> **NCT00578929** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 2388 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Olopatadine Hydrochloride Nasal Spray 0.6%
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00578929
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-11
- **Final completion:** —
- **Target enrollment:** 2388 (ACTUAL)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578929, "Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00578929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*